Dow-DuPont merger hits delays as EU demands missing deal info
Dow Agrosciences parent Dow Chemical Co. and DuPont Co. face further delays to their plans to create the world’s biggest chemical company
Life Science & Biotech
Articles
Dow Agro sales rise on strong demand for seeds
Indianapolis-based Dow AgroSciences said sales and operating earnings rose in the third quarter, thanks in part to strong demand for products in Latin America. Meanwhile, the massive merger between parent Dow Chemical and DuPont has been delayed.
Indy-based NICO works for acceptance of less invasive brain surgery tools
Currently, only about 2-4 percent of U.S. brain surgeries for tumors, strokes and other abnormalities are done with NICO’s low-invasive approach.
Lilly’s Elanco unit buying pet-vaccine portfolio for $885M
The Indianapolis drugmaker's animal-health division is bulking up its companion-animal business by buying Boehringer Ingelheim International's U.S. feline, canine and rabies medications.
Indiana Biosciences Research Institute picks chief scientific officer
Rainer Fischer most recently served as senior executive director of the Fraunhofer Institute for Molecular Biology and Applied Ecology in Germany. The institute is part of the largest applied science research organization in Europe.
New firm focuses on innovations, including ‘ear in a dish’
In a Q&A, Monon Bioventures CEO Joe Trebley talks about the goals and ambitions of his one-year-old firm.
Verdure Sciences plans to build $3.5M HQ in Noblesville
Verdure Sciences has filed plans with Noblesville to build a 15,000-square-foot facility on a 7-acre property in the Metro Enterprise Park near the southwest corner of Pleasant Street and Union Chapel Road.
Bayer signs deal to acquire Monsanto for $66 billion
Bayer AG has agreed to buy Monsanto Co. in a deal valued at $66 billion, winding up four months of talks to create the world’s biggest supplier of seeds and pesticides.
DuPont-Dow merger faces big EU obstacle
European antitrust officials decided this month to launch a full-blown investigation into the proposed merger Dow Chemical Co. and DuPont Co.
Purdue’s $6.25 million plant-mapping project approved
The State Budget Committee has given its approval for Purdue University to build a high-tech, greenhouse-like facility where scientists will map plant genomes.
CEO Ellis resigns after 20 years at struggling drug firm Endocyte
The West Lafayette-based company has named CFO and COO Mike Sherman as new CEO and president, but did not give a reason for the abrupt change in leadership.
Biotech firm lands funding for cancer targeting
Animated Dynamics Inc. has raised $1.7 million in early funding to help it get its technology to market.
Zimmer Biomet to buy LDR for $1B to add spine devices
Indiana-based Zimmer Biomet Holdings Inc. has agreed to buy LDR Holding Corp. for about $1 billion in cash to add surgical technologies for the treatment of patients with spine disorders.
Medical firms, universities drive increase in Indiana patents
Indiana inventors secured 30 percent more patents in 2015 than they did four years earlier.
And at more than 2,000, last year’s number is double the patents granted to Hoosiers in 2008, a low point for patents in the past two decades.
Germany’s Bayer makes $62 billion offer for Monsanto
The news is the latest example of a huge shakeup in the agricultural industry.
Indiana needs to address brain drain, BioCrossroads study finds
While many college graduates are leaving the state, jobs in health care and life sciences in Indiana are booming, and employers are often searching high and low for talent.
IBJ Life Sciences Power Breakfast transcript – 2016
IBJ gathered leaders in the life sciences industry for a Power Breakfast panel discussion April 21. Panel members included Colleen Hittle, managing director of Navigant; Suresh Garimella, Purdue University’s executive vice president of research and partnerships; Brian Barker, general manager of U.S. Seeds for Dow AgroSciences; Kristin Sherman, former chief financial officer of Calibrium LLC; and David Johnson, CEO of BioCrossroads.
Dow Agro’s revenues slide ahead of DuPont merger
Indianapolis-based agricultural Dow Agro on Thursday said revenue in the first quarter was $1.6 billion, down 16 percent from a year ago, as the company was hurt by high inventories, currency headwinds and lower prices.
State’s life sciences sector on rise while struggling with talent, capital
Shortages of workers and investment dollars remain the two biggest challenges for Indiana’s life sciences industry, which otherwise is showing robust vital signs and embarking on high-profile collaborations.
Indy airport board cancels $500M medical plan; to reopen bidding
The Indianapolis Airport Authority board said it would “leave our options open and continue to search for the optimal project.”